课题基金 / 基金详情

项目摘要

项目成果

NAGI B. KUMAR的其他基金

相似基金

相关文献

中文摘要
翻译
USF-Moffitt跨学科研究培训/教育核心的总体目标 CHD-COE旨在培养一支有能力、训练有素的少数民族研究人员和医疗保健专业人员队伍 他将准备有效地解决佛罗里达州和美国各地的癌症差异问题。 美国通过跨学科研究。RTEC活动的目标人群将是 学生在他们的教育(本科,研究生,博士,博士后)的整个连续性,以及 作为初级,高级教师和社区合作伙伴/成员。我们建议建立这种合作关系, 企业的基础上的综合经验,成功和挑战的类似计划,已 在两个机构分别制定和实施了一项关于研究、教育和培训 癌症差异此外,根据跨学科(人口、基础和临床)的主题, 我们将把RTEC活动的重点放在不成比例的癌症发病率上, 少数民族和服务不足人口的死亡率。为了实现这些总体目标,我们将利用 USF-Moffitt指导委员会、外部咨询委员会的知识和专业知识(描述 详细内容见第五节B),将为发展和维持这一核心提供必要的领导。
英文摘要
The overall goal of the Research Training/Education Core (RTEC) of USF-Moffitt Transdisciplinary CHD-COE is to develop a cadre of competent, well-trained minority researchers and healthcare professionals who will be prepared to effectively address cancer disparity in the state of Florida and around the United States of America through transdisciplinary research. The target population for the RTEC activities will be students in the entire continuum of their education (undergraduate, graduate, doctoral, post-doctoral), as well as junior, senior faculty and community partners/members. We propose to establish this collaborative enterprise based on the combined experiences, successes and challenges of similar programs that have been developed and implemented in the two respective institutions to address research education and training in cancer disparity. In addition, keeping with the theme of transdisciplinary (population, basic and clinical sciences) cancer research, we will focus the RTEC activities on the disproportionate cancer morbidity and mortality in minority and underserved populations. To meet these overall goals, we will draw upon the knowledge and expertise of the USF-Moffitt Steering Committee, the External Advisory Committee (described in detail in Section: V,B), will provide leadership necessary for developing and sustaining this Core.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase II Clinical trial of GTC in Men on Active Surveillance
Phase II Clinical trial of GTC in Men on Active Surveillance
Phase II Clinical trial of GTC in Men on Active Surveillance
Phase II Clincal Trial of Purified Isofavones in Prostate Cancer: Comparing Safet
  • 批准号:
    8412706
  • 项目类别:
  • 资助金额:
    $10.84万
  • 财政年份:
    2013
  • 负责人:
    NAGI B. KUMAR
  • 依托单位:
海外基金